SweetValueLab
Write for us

Agilent Technologies, Inc. — Financial Statements & Ratios

A
NYSEHealthcareMedical - Diagnostics & ResearchCIK 0001090872agilent.comAbout A
Last close · Oct 16, 2026172.97−2.58 (−1.47%)
Market cap$48.8B

Key indicators

Revenue7.4BTTM+8.6% on a year earlier+5.1% a year, FY2018–FY2025
Fiscal yearFY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025TTMFY2026EFY2027EFY2028E
Growth
4.9B 5.2B+5.1%5.3B+3.4%6.3B+18.4%6.8B+8.4%6.8B−0.2%6.5B−4.7%6.9B+6.7%7.4B+8.6%7.5B 8.0B 8.5B
— 5.1% 3.4% 18.4% 8.4% -0.2% -4.7% 6.7% 8.6% 8.0% 6.5% 6.5%
$0.97 $3.37+247.4%$2.30−31.8%$3.94+71.3%$4.18+6.1%$4.19+0.2%$4.43+5.7%$4.57+3.2%$5.08+19.0%$6.20 $6.74 $7.44
Profitability
18.9% 18.2%−0.7 pt15.8%−2.4 pt21.3%+5.5 pt23.6%+2.3 pt19.8%−3.9 pt22.9%+3.1 pt21.3%−1.6 pt22.2%+1.0 pt· · ·
6.4% 20.7%+14.3 pt13.5%−7.3 pt19.1%+5.7 pt18.3%−0.8 pt18.1%−0.2 pt19.8%+1.7 pt18.8%−1.0 pt19.5%+1.6 pt· · ·
6.9% 22.6%+15.6 pt14.8%−7.8 pt22.5%+7.7 pt23.6%+1.2 pt21.2%−2.4 pt21.9%+0.6 pt19.3%−2.5 pt— · · ·
Cash
910.0M 866.0M−4.8%802.0M−7.4%1.3B+61.7%1.0B−21.3%1.5B+44.4%1.4B−6.9%1.2B−16.1%1.3B+16.5%· · ·
18.5% 16.8%−1.7 pt15.0%−1.8 pt20.5%+5.5 pt14.9%−5.6 pt21.6%+6.7 pt21.1%−0.5 pt16.6%−4.5 pt17.2%+1.2 pt· · ·
191.0M 206.0M+7.9%222.0M+7.8%236.0M+6.3%250.0M+5.9%265.0M+6.0%274.0M+3.4%282.0M+2.9%— · · ·
Balance sheet
0.39x 0.51x+0.11x0.48x−0.02x0.51x+0.02x0.52x+0.02x0.47x−0.05x0.57x+0.11x0.50x−0.08x0.54x+0.00x· · ·
325.00M 318.00M−2.2%312.00M−1.9%307.00M−1.6%300.00M−2.3%296.00M−1.3%291.00M−1.7%285.00M−2.1%283.00M−0.7%· · ·

E = analyst consensus (revenue and EPS only). TTM = the twelve months to Jul 31, 2026: the last fiscal year, plus the quarters since, less the same quarters a year earlier. From the 10-K and the 10-Qs since, as accepted by the SEC; the shaded column is the latest period.